This inventor holds 1 USPTO granted patent and 10 published patent applications and 1 EPO patent. Top assignee: Kainos Medicine Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Minjeong Choi: Innovator in Cancer Treatment
Introduction
Minjeong Choi is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Minjeong Choi holds a patent for "Bromodomain-inhibiting compounds and pharmaceutical composition comprising same for preventing or treating a cancer." This novel compound exhibits bromodomain and extra terminal domain (BET) protein inhibiting activities. The pharmaceutical composition derived from this compound is useful for the prevention or treatment of precancerous transformation or cancer.
Career Highlights
Choi is currently associated with Kainos Medicine Inc., where he continues to advance his research in oncology. His work focuses on developing effective treatments that can significantly impact patient outcomes.
Collaborations
Minjeong Choi collaborates with Su-Sung Oh, who is also involved in the research and development efforts at Kainos Medicine Inc. Their partnership enhances the innovative capabilities of the company.
Conclusion
Minjeong Choi's contributions to cancer treatment through his patented innovations highlight the importance of research in developing effective therapies. His work at Kainos Medicine Inc. continues to pave the way for advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile